Goliber
Cynthia A. Goliber, Phoenixville, PA US
Patent application number | Description | Published |
---|---|---|
20090076783 | Digitally optimized fastener assembly and method of making the same - A method of making a digitally optimized fastener assembly for a disposable absorbent article can have the following steps: creating a first FEA model having first structural design properties and/or first material design properties; analyzing the first FEA model to obtain first failure characteristics; modifying the first structural design properties and/or the first material design properties to create a second FEA model having second structural design properties and/or second material design properties; analyzing the second FEA model to obtain second failure characteristics thereof; comparing the first failure characteristics to the second failure characteristics to determine whether there is an improvement over the first failure characteristics; and wherein the third through fifth steps can be repeated until a FEA model is created which exhibits desirable failure characteristics. A digitally optimized fastener assembly generally be a fastener assembly made according to the aforesaid method. | 03-19-2009 |
20100032114 | Compositions containing expandable microspheres and an ionic compound as well as methods of making and using the same - This invention relates to composition containing expandable microspheres and at least one ionic compound and having a zeta potential that is greater than or equal to zero mV at a pH of about 9.0 or less at an ionic strength of from 10 | 02-11-2010 |
20110277949 | Compositions containing expandable microspheres and an ionic compound, as well as methods of making and using the same - This invention relates to composition containing expandable microspheres and at least one ionic compound and having a zeta potential that is greater than or equal to zero mV at a pH of about 9.0 or less at an ionic strength of from 10 | 11-17-2011 |
20130146240 | COMPOSITIONS CONTAINING EXPANDABLE MICROSPHERES AND AN IONIC COMPOUND, AS WELL AS METHODS OF MAKING AND USING THE SAME - This invention relates to composition containing expandable microspheres and at least one ionic compound and having a zeta potential that is greater than or equal to zero mV at a pH of about 9.0 or less at an ionic strength of from 10 | 06-13-2013 |
Cynthia A. Goliber, Phoenxville, PA US
Patent application number | Description | Published |
---|---|---|
20100032115 | Compositions containing expandable microspheres and an ionic compound as well as methods of making and using the same - This invention relates to composition containing expandable microspheres and at least one ionic compound and having a zeta potential that is greater than or equal to zero mV at a pH of about 9.0 or less at an ionic strength of from 10 | 02-11-2010 |
Philip A. Goliber, Lasne BE
Patent application number | Description | Published |
---|---|---|
20090030026 | Sustained release formulations of nalbuphine - Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided. | 01-29-2009 |
20130164350 | SUSTAINED RELEASE FORMULATION OF NALBUPHINE - Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided. | 06-27-2013 |
20140271852 | SUSTAINED RELEASE FORMULATION OF NALBUPHINE - Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided. | 09-18-2014 |
20140315937 | SUSTAINED RELEASE FORMULATION OF NALBUPHINE - Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided. | 10-23-2014 |